Champions Oncology, Inc.
- Nasdaq
- CSBR
- CIK
- 771856
- Based in
- Baltimore, Maryland
- Incorporated in
- Delaware
- Fiscal year ends
- April 30
- SEC filer category
- Non-accelerated filer, Smaller reporting company
- Employer ID (EIN)
- 52-1401755
- Formerly
- Champions Biotechnology, Inc., Champions Sports Inc
Key figures
| Fiscal year to | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 |
|---|---|---|---|---|---|
| Revenue | $59.4M | $56.9M | $50.2M | $53.9M | $49.1M |
| Operating income | −$1.14M | $4.55M | −$7.36M | −$5.26M | $607.0K |
| Net income | −$1.18M | $4.70M | −$7.28M | −$5.33M | $548.0K |
| Diluted EPS | −$0.08 | $0.33 | −$0.54 | −$0.39 | $0.04 |
| Cash from operations | −$4.47M | $7.39M | −$6.14M | $3.97M | $6.50M |
| Total assets | $27.0M | $32.3M | $26.1M | $34.3M | $35.4M |
| Shareholders’ equity | $3.94M | $3.77M | −$1.90M | $4.64M | $9.10M |
From the company’s annual reports to the SEC. Each year links to its report.
Financials 85
- 10-Q Quarterly Report for period ending Jul 31, 2026
- 10-K Annual Report for period ending Apr 30, 2026
- 10-Q Quarterly Report for period ending Jan 31, 2026
- 10-Q Quarterly Report for period ending Oct 31, 2025
- 10-Q Quarterly Report for period ending Jul 31, 2025
- 10-K Annual Report for period ending Apr 30, 2025
- 10-Q Quarterly Report for period ending Jan 31, 2025
- 10-Q Quarterly Report for period ending Oct 31, 2024
- 10-Q Quarterly Report for period ending Jul 31, 2024
- 10-K Annual Report for period ending Apr 30, 2024
News 160
Ownership 271
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Ackerman Joel: Change in insider ownership
- 4 Ackerman Joel: Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 3 Initial statement of insider ownership
- 4 Change in insider ownership
- 4 Sidransky David: Change in insider ownership
Prospectus 8
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- 424B4 Prospectus filed pursuant to Rule 424(b)(4)
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1 General form of registration statement for all companies including face-amount certificate companies
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- 424B3 Prospectus filed pursuant to Rule 424(b)(3)
- S-1 General form of registration statement for all companies including face-amount certificate companies
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Proxies 36
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEF 14A Definitive proxy statements
- DEF 14A Definitive proxy statements
Other 99
- UPLOAD Letter (PDF)
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- UPLOAD Letter (PDF)
- EFFECT Notice of Effectiveness
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- UPLOAD Letter (PDF)
- EFFECT Notice of Effectiveness
- POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing